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Summary
Background: Nucleotide excision repair is a versatile DNA
repair reaction that removes bulky adducts generated by envi-
ronmental mutagens such as the UV spectrum of sunlight
or chemical carcinogens. Current multistep models of this
excision repair pathway accommodate its broad substrate
repertoire but fail to explain the stringent selectivity toward
damaged nucleotides among excess native DNA. To under-
stand the mechanism of bulky lesion recognition, we postu-
lated that it is necessary to analyze the function of xeroderma
pigmentosum group D (XPD) protein beyond its well-known
role in the unwinding of double-stranded DNA.
Results: We engineered two new XPD mutants (Y192A and
R196E), involving amino acid substitutions near its central
protein pore, that confer defective DNA repair despite normal
transcription. In situ fluorescence-based protein dynamics
studies in living cells demonstrated that both new mutants
were unable to recognize DNA damage and failed to form
stable associations with lesion sites. However, when their
biochemical properties were tested in the framework of an
archaeal protein homolog, they both retained ATPase and
DNA-unwinding activity. The outstanding difference versus
the wild-type control was that their directional 50–30 transloca-
tion along DNA was not stopped by a bulky lesion, and
moreover, they were unable to build long-lived demarcation
complexes at damaged sites.
Conclusions: By uncoupling for the first time the unwinding
and damage sensor activities of XPD, we describe an
unprecedented genome quality control process whereby a
recognition pocket near the central DNA helicase pore scans
individual substrate strands to capture base adducts.Introduction
A versatile DNA repair machinery known as nucleotide exci-
sion repair (NER) promotes genome stability by removing
bulky base lesions induced by a diversity of genotoxic insults
including the UV radiation of sunlight, chemical carcinogens,
metabolic byproducts, and oxygen radicals [1–4]. This defense
reaction consists of two subpathways. Global genome repair,
which takes place across the entire genome, is initiated by the
xeroderma pigmentosum group C (XPC) complex [5–8]. The
second subpathway, transcription-coupled repair, is triggered
by the stalling of RNA polymerase II and hence targets the3These authors contributed equally to this work
*Correspondence: naegelih@vetpharm.uzh.chtranscribed strand of active genes [9, 10]. These two reaction
branches converge into a common repair pathway with the
recruitment of the multifunctional transcription factor IIH
(TFIIH), whose two subunits with unwinding activity (xero-
derma pigmentosum group B and D; XPB and XPD) are abso-
lutely necessary to generate a melted DNA intermediate
amenable to DNA damage excision [11–13]. At this stage of
NER activity, XPB functions as an ATPase, whereas XPD
also displays a processive 50–30 helicase action and hence
provides a directional tracking engine [14, 15]. Mutations in
the XPD gene give rise to hereditary disorders including xero-
derma pigmentosum (XP), which predisposes to cancer, as
well as Cockayne syndrome (CS) and trichothiodystrophy
(TTD), characterized by developmental and neurologic deficits
as well as traits of premature aging [16–18].
Although XPC protein, the initiator of global genome repair,
is thought to detect distortions of the DNA double helix, it
displays only a limited selectivity for many common NER
substrates, including for example cyclobutane pyrimidine
dimers (CPDs) induced by UV light [7, 19–21]. Particularly in
the condensed chromatin context of living cells, XPC also
associates extensively with the native double helix [22–24],
thus highlighting its inability to clearly distinguish between
damaged and undamaged DNA. Such findings raise the ques-
tion of whether a downstream NER factor like TFIIH may be
required to actually recognize or verify the presence of bulky
DNA lesions before triggering the NER reaction [25–27].
Previous biochemical assays indeed suggest that the TFIIH
complex may contribute to the search for bulky DNA damage
[28]. However, it has never been shown conclusively whether
damage recognition or verification by TFIIH, besides its
unwinding function, is a true prerequisite for NER activity.
Also, the mechanism of this proposed damage verification
process has remained elusive.
Here, we tested the hypothesis that the directional tracking
activity of the XPD subunit of TFIIH, besides its role in duplex
unwinding, may serve as a molecular sensor to ‘‘read’’ the
chemical integrity of DNA. This hypothesis was prompted by
crystal structure analyses of archaeal XPD homologs revealing
a doughnut-like folding whereby two RecA-like domains, an
arch-like domain and an iron-sulfur cluster (FeS), build
a deep channel and central hole that can accommodate
single-stranded DNA [29–32]. These structural studies imply
that DNA unwinding occurs by threading single DNA strands
through this channel and the adjacent hole, thus bringing
XPD in a strategic position to get into close contact with
base lesions. Here, we demonstrate that the XPD helicase
detects damaged substrates by a molecular interplay with
such offending bases immediately before they enter the
central protein pore, thereby revealing for the first time the
mechanism of DNA lesion verification in a multilayered
damage recognition process.
Results
NER Activity of XPD Mutants
The purpose of this study was to introduce amino acid
changes by which XPD retains its ATPase and helicase activity
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Figure 1. Generation of New XPD Mutants Target-
ing Evolutionarily Conserved Residues near the
Central Protein Pore
(A) Screening of NER activity by host-cell reactiva-
tion assay in XP-D fibroblasts. NER capacity
(indicated as percentage of wild-type control) is
determined by the ratio of Photinus and Renilla
luciferase production from UV-irradiated (pGL3)
and undamaged reporter plasmid (pRL-TK),
respectively (n = 6, 6SD). ‘‘Empty’’ indicates XP-
D cells transfected with control expression vector
coding only for GFP.
(B) Structural model illustrating the localization of
Y192 and R196, defining a lesion recognition
pocket in close proximity to the central pore of
XPD protein (PDB accession code 4A15). FeS,
iron-sulfur cluster. See Figure S1B for the full
structure of archaeal XPD homologs [29–32].
(C) Stimulation of CPD excision in UV-irradiated
(10 J/m2) CHO cells by wild-type XPD and selected
mutants (n = 5, 6SD). CPD levels were measured
by immunoassay analysis of genomic DNA.
(D) Stimulation of transcription in XP-D cells. The
transcriptional activity (indicated as percentage
of wild-type control) is determined by the amount
of Photinus luciferase production from the undam-
aged reporter plasmid pGL3 (n = 6, 6SD).
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205but loses the ability to discriminate between undamaged and
damaged DNA during the unwinding reaction. Therefore,
evolutionarily conserved residues in the proximity of the
central hole, but not belonging to the distinctive signature
motifs characteristic of DNA and RNA helicases [33] (see
Figure S1A available online), were selected for site-directed
mutagenesis. To test for functional implications, we performed
a host-cell reactivation assay that determines the cellular NER
capacity using a dual luciferase reporter system [34, 35]. NER-
deficient XP-D fibroblasts were transfected with three
constructs: a UV-irradiated (254 nm wavelength, 1,000 J/m2)
reporter plasmid containing the Photinus luciferase sequence,
an undamaged control encoding the Renilla luciferase, and an
expression vector for XPD fused to green fluorescent protein
(GFP). Upon transfection, the NER machinery is needed to
remove UV lesions from the irradiated reporter plasmid and
allow for Photinus luciferase production. Finally, NER effi-
ciency is monitored by measuring luciferase levels in cell
lysates and recorded as the ratio ofPhotinus toRenilla activity.
The tested XP-D fibroblasts carry heterozygote mutations
where one allele codes for an R683W substitution and the
second allele yields a deletion of codons 36–61. Thus, XP-D
cells that were transfected to express XPD-GFP containing
the K48R mutation (located in helicase motif I) display only
a background NER capacity equal to that detected with the
empty GFP control (Figure 1A). This finding is consistent with
a low residual NER function in XP-D cells and the inability of
the enzymatically inactive K48R mutant to complement this
deficiency [36]. A full repair activity is reestablished by expres-
sion of XPD-GFP displaying the wild-type sequence. Instead,
the newly generated XPD mutations at codons Y192 and
R196, although located outside the canonical helicase motifs,
confer a NER defect as demonstrated by the low expression
of Photinus luciferase. In the case of codon 196, a charge
inversion by replacement with glutamic acid (R196E) caused
a stronger reduction of NER activity than substitutions withthe nonpolar alanine (R196A) or the positively charged lysine
(R196K). For comparison, we introduced amino acid changes
at positions D131 (mapping to a region between helicase
motifs I and II) and K603 (mapping to helicase motif V), thereby
obtaining different degrees of NER inhibition (Figure 1A). We
also tested the known patient mutations Y542C, D673G, and
G675R. Consistent with previous studies revealing that these
pathological substitutions affect ATPase and DNA helicase
functions [29, 30], the corresponding XPD derivatives are
unable to correct the NER deficiency of XP-D cells.
To summarize, an initial screen by host-cell reactivation
assay indicated that the Y192A and R196E mutations, buried
in the deep DNA-binding channel in proximity to the central
protein pore (Figures 1B and S1B), lead to diminished DNA
repair. This conclusion was confirmed by monitoring the exci-
sion of UV damage from the genome of Chinese hamster ovary
(CHO) cells with an immunoassay using antibodies against
CPDs, the main type of bulky UV lesion. On their own, these
rodent cells are characterized by slow repair of CPDs because
they lack the damaged DNA-binding protein DDB2 that
enhances CPD recognition [37]. However, we observed that
wild-type XPD-GFP stimulates the excision of CPDs compared
to mock transfections with empty GFP vectors (Figure 1C),
implying that the ectopic overexpression of human XPD
compensates, under the condition of this study, for the UV
lesion recognition deficiency of CHO cells. This novel obser-
vation was exploited to assess the NER capacity of different
XPD constructs, confirming that the enzymatically inactive
K48R mutant fails to support CPD excision. Similarly, the
Y192A substitution generates an XPD mutant that is unable
to stimulate repair activity, and also the R196E change
resulted in less CPD excision. During an initial 8 hr incubation,
the observed DNA repair stimulation was reduced by as
much as 99.4% and 65.5% with the Y192A and R196E muta-
tions, respectively, in comparison to the wild-type reference
(Figure 1C).
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A Figure 2. Recognition of UV Lesions in the Nuclei
of Living Cells
(A) Typical series of images obtained when XPD
protein dynamics were analyzed by FRAP. The
postbleaching fluorescence recovery results
from themovement of fluorescent proteins within
the nuclear compartment.
(B) Delayed nuclear dynamics of wild-type XPD-
GFP in UV-irradiated cells due to the recognition
of UV lesions (n = 15, 6SEM).
(C–E) Defective recognition of UV lesions by
mutated XPD carrying the indicated amino acid
substitutions (n = 15, 6SEM).
Current Biology Vol 23 No 3
206The concurrent transcriptional activity has been determined
to rule out the possibility that the tested amino acid substitu-
tions derange DNA repair by interfering grossly with XPD
protein folding or subunit assembly in the TFIIH complex. For
that purpose, wemade use of the observation that transfection
of XP-D fibroblasts with the wild-type XPD-GFP construct
stimulates luciferase expression from an undamaged reporter
plasmid compared to controls carrying the empty GFP vector
(Figure 1D). This effect is likely due to a subtle transcriptional
defect of XP-D cells conferred by the R683W mutation in the
remaining functional XPD allele, presumably disturbing the
overall TFIIH structure [38]. The enhancement of reporter
gene expression observed in the presence of wild-type XPD
provides an opportunity to gauge the transcriptional activity
of XPD mutants. Interestingly, at least the same stimulation of
reporter gene expression is detected with all XPD constructs
except K603A (Figure 1D), indicating that, despite their func-
tional defect in repair, these mutants still display sufficient
structural integrity to support transcription.
Nuclear Dynamics of XPD Mutants
The next question was whether the XPD mutations K48R,
Y192A, and R196E diminish DNA repair by interfering with
the proper interaction of XPD with UV lesions. To that
end, we expressed XPD-GFP fusions in CHO cells and deter-
mined their overall nuclear mobility by fluorescence recovery
after photobleaching (FRAP). In this real-time technique, a
4 mm2 nuclear area was photobleached with a laser (488 nmwavelength) to locally suppress the
fluorescence signal. The subsequent
recovery of green fluorescence, result-
ing from the progressive movement
of XPD-GFP molecules into the
bleached nuclear area, was recorded
over time (Figure 2A). Upon UV irra-
diation (254 nm), the fluorescence
recovery of wild-type XPD is reduced
in a dose-dependent manner, reflecting
restrained protein mobility due to inter-
actions with DNA damage (Figure 2B).
The elevated UV dose of 150 J/m2 was
included to confront the NER system
with a high lesion density. However,
the nuclear dynamics of the mutant
XPD proteins K48R, Y192A, and R196E
were not altered by any of these UV
treatments (Figures 2C–2E), indicating
that, unlike the wild-type control, their
movement remained unaffected.A possible caveat of the protein dynamics studies of Fig-
ure 2 is that the mobility of XPD mutants was generally lower
than wild-type in the absence of DNA damage such that these
reduced protein dynamics might obscure a transient recruit-
ment to damaged sites. As a consequence, we conducted
further imaging experiments to analyze in detail the interaction
of each mutant with DNA lesions in the chromatin context.
For that purpose, CHO cells transfected with the different
XPD-GFP constructs were UV irradiated through the pores
of polycarbonate filters, followed by visualization of the result-
ing spots of UV damage by immunostaining with an antibody
against CPDs. It was expected from previous reports using
the inactivating K48R substitution [39, 40] that the tested
XPD mutants, as long as they associate with the TFIIH
complex, would be recruited to the vicinity of UV-damaged
sites. Indeed, all tested XPD-GFP constructs, wild-type or
mutant, accumulated at the sites of CPD formation, confirm-
ing that the fusion proteins are incorporated into TFIIH
complexes and therefore are recruited to damaged DNA sites
(Figure 3A). However, the quantitative comparison of local
fluorescence intensity over the surrounding nuclear back-
ground, in cells expressing equal overall levels of XPD-GFP
fusions, revealed an intriguing difference in the degree
of damage-specific protein accumulation. Wild-type XPD
reached the highest fluorescence intensity at lesion sites
and hence a stronger UV-dependent accumulation than the
mutants K48R, Y192A, and R196E, which relocated to UV sites
less efficiently (Figure 3B).
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Figure 3. Stability of DNA Damage Recognition
Intermediates in the Nuclei of Living Cells
(A) Formation of spots of UV lesions (CPDs) by
irradiation throughmicropore filters and accumu-
lation of XPD-GFP at the sites of DNA damage.
The DNA is visualized by staining with Hoechst
reagent.
(B) Quantification of XPD-GFP fusions that accu-
mulate at spots of UV lesions in comparison to
the overall expression (as percentage of wild-
type control; n = 30, 6SEM).
(C) Residence time of XPD-GFP fusions at
UV lesion spots determined by FRAP-LD (n =
15, 6SEM).
(D) UV-dependent sequestration of XPD-GFP
in chromatin visualized by MNase digestion.
‘‘Free’’ indicates fraction of non-chromatin-
bound XPD-GFP removed by salt extraction
(0.3 M NaCl) before MNase treatment. TBP,
TATA-binding protein used as a marker of chro-
matin-bound proteins susceptible to MNase
solubilization.
See also Figure S2.
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bution was examined by FRAP on local damage (FRAP-LD)
analyses. Briefly, the fluorescence of individual green spots
of XPD-GFP accumulation at lesion sites was photobleached
to reduce the local intensity to that of the nuclear background.
The fluorescence recovery due to an exchange of bleached
XPD-GFP molecules on lesion sites with nonbleached coun-
terparts from surrounding undamaged regions was then
monitored over time, thereby providing real-time kinetics of
the interplay between XPD protein and DNA lesions. The re-
sulting fluorescence recovery curves revealed that a large
proportion of wild-type XPDpersists at lesion sites (Figure 3C).
In contrast, as demonstrated earlier [40], the K48R active-site
mutant was released rapidly and completely from UV lesions.
In this study, similarly fast dissociations were detected with
the newmutants Y192A andK196E (Figure 3C). Representative
FRAP-LD images generated with wild-type and mutant XPD
are shown in Figure S2. The diverging FRAP-LD recovery
curves indicate that, like K48R, the Y192A and R196E substitu-
tions result in reduced immobilization at DNA damage. We
therefore concluded that residues Y192 and R196 are required
for the formation of stable lesion recognition intermediates.Prompted by these findings, we used
a standard chromatin digestion assay
[41] to visualize the fraction of XPD-
GFP that, in UV-irradiated CHO cells,
becomes closely associated with
damaged DNA. First, the free XPD-GFP
molecules not bound to chromatin
were removed by salt (0.3 M NaCl)
extraction. Second, the remaining XPD-
GFP moieties interacting tightly with
chromatin were released by chromatin
solubilization through micrococcal
nuclease (MNase) digestion. As shown
in Figure 3D, this treatment demon-
strated that part of wild-type XPD is
sequestered in chromatin upon UV
irradiation. However, none of the mutant
proteins formed a comparable asso-
ciation with damaged chromatin, thusconfirming their inability to induce stable recognition inter-
mediates. To rule out that the 0.3 M NaCl washing step might
inadvertently remove XPD mutants from DNA, we repeated
the same experiment using 0.05 and 0.15 M NaCl, but in both
cases the mutant proteins remained unable to associate with
damaged chromatin despite the lower salt concentration.
DNA-Binding Capacity of XPD Mutants In Vitro
Next, the role of residues Y192 and R196 in damage recogni-
tion was tested in the framework of a monomeric XPD
homolog from Ferroplasma acidarmanus (FaXPD) that is
closely related in sequence and, unlike other frequently used
archaeal homologs, active at moderate temperature, thus
providing an excellent model enzyme for the human counter-
part [42, 43]. The archaeal residues K37 (corresponding to
K48 in human XPD), Y171 (Y192 in human XPD), R175 (R196
in human XPD), andK523 (K603 in human XPD; see Figure S1A)
were mutated, and the resulting FaXPD derivatives, fused to
an N-terminal His6 tag, were produced in Escherichia coli
and purified to homogeneity (Figure S3A). To facilitate
comparisons, the human codon numbering has been adopted
for the corresponding FaXPD residues.
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Figure 4. Binding of FaXPDProteins to Undamaged
and Damaged DNA Substrates
(A) Scheme of forkedDNA substrates illustrating the
position of a single CPD.
(B) Representative electrophoretic mobility shift
assay demonstrating that the association of FaXPD
with DNA substrate (5 nM) is not affected by the
presence of a single CPD.
(C) Quantification of mobility shift assays carried
out with wild-type FaXPD (n = 5, 6SD).
(D–F) Quantification of mobility shift assays per-
formed with mutant FaXPD proteins containing
the indicated amino acid substitutions (n = 5,6SD).
See also Figure S3.
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and the K603A mutant, where an amino acid substitution in
helicase motif V was expected to interfere with substrate inter-
actions. Electrophoretic mobility shift assays were carried out
using forked DNA duplexes consisting of 81 bp segments
flanked by single-stranded arms of 44 nucleotides (Fig-
ure S3B). These DNA-binding assays revealed that wild-type
FaXPD readily forms nucleoprotein complexes and that the re-
sulting associations saturate at protein concentrations around
60 nM (Figure S3C). In comparison, the K603A mutant exhibits
a markedly reduced DNA-binding activity at low protein
concentrations, and accordingly, higher amounts of mutant
FaXPD are needed to achieve binding saturation (Figure S3D).
Further mobility shift assays using oligonucleotides contain-
ing a lesion demonstrated that a single CPD in the duplex
region of forked DNA (Figure 4A) does not interfere with the
association of FaXPD with its substrate (Figures 4B and 4C).
Similarly, no differences were observed between the DNA
binding of the K48R variant in the presence or absence of
a CPD (Figure 4D). Conversely, the mutations Y192A and
R196E reduce the binding of FaXPD to the forked DNA
substrate, but only at low protein concentrations (Figures 4E
and 4F). Importantly, with both mutants, protein-DNA interac-
tions were saturated at a FaXPD concentration around 60 nM,
and in all cases, the presence of a CPD did not interfere with
their DNA-binding properties. The resulting equilibrium disso-
ciation constants (KD), reflecting the affinity for forked DNA,
were 20 nM (for wild-type XPD and the K48R mutant), 31 nM
(for R196E), 34 nM (for Y192A), and 45 nM for the K603A
mutant, the lowest affinity detected.
Failure of XPD Mutants to Sense Damage during DNA
Unwinding
The same forked substrates were used to test the conse-
quences of a collision with base lesions during DNAunwinding. The DNA helicase activity of
wild-type FaXPD is severely inhibited
when encountering a single CPD located
in the 50–30 translocated strand [40]
(Figure 5A). By extending this analysis
to the Y192A and R196E mutants, we
noted that, at the FaXPD protein concen-
tration of 60 nM or higher (the DNA-satu-
rating range in the binding assays of
Figure 4), strand displacement from
the undamaged duplex was only margin-
ally reduced compared to the wild-type
control. The outstanding finding wasthat, independently of protein concentration, the DNA helicase
activity of the Y192A and R196E mutants is not affected by
a CPD lesion (Figures 5B and 5C). Thus, both mutants are
able to progress to the substrate termini and achieve complete
strand separation after overriding the template lesion, indi-
cating that residues Y192 and R196 are necessary to sense
DNA damage. The other tested FaXPD derivatives (K48R and
K603A) were devoid of DNA-unwinding activity (data not
shown), consistent with the fact that residues K48 and K603
are located within the evolutionarily conserved helicase
motifs.
We also tested the corresponding ATPase activity in the
presence or absence of a CPD in forked DNA substrates.
Neither the wild-type FaXPD enzyme nor the Y192A and
R196E mutants were affected by the presence of a CPD
lesion with regard to their ability to promote ATP hydrolysis
(Figure S4). On the other hand, this ATPase activity was
completely abolished with the K48R and K603 mutants (data
not shown), which is in line with the concomitantly missing
helicase function.
Failure of XPD Mutants to Form a Stable Verification
Intermediate
We previously established competition and nuclease protec-
tion assays to demonstrate that FaXPD generates a stable
complex with DNA after running into a CPD lesion [40]. For
example, preincubationofwild-typeFaXPDwith a radiolabeled
51-mer DNA oligonucleotide generates nucleoprotein com-
plexes that, in the presence of ATP, disappear after the
addition of a 50-fold molar excess of unlabeled 51-mer (Fig-
ure 6A). In these reactions, which contain ATP and undamaged
substrate, FaXPD moves to the 30 end, where it is released
from the labeled oligonucleotide and reassociates preferen-
tially with nonlabeled competitors. Instead, in reactions con-
taining no ATP or supplemented with the nonhydrolyzable
AB
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Figure 5. Differential Unwinding of Damaged DNA Duplexes
(A) A single CPD inhibits the DNA helicase activity exerted by wild-type
FaXPD on forked substrates. The panel on the right shows the quantification
of five independent experiments (6SD).
(B) The same CPD substrate fails to inhibit DNA unwinding by the Y192A
mutant (n = 5, 6SD).
(C) Similarly, the CPD is unable to inhibit DNA unwinding by the R196E
mutant (n = 5, 6SD).
See also Figure S4.
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209analog ATPgS, the FaXPD enzyme cannot move to the 30
terminus and hence fails to dissociate giving rise to stable
complexes refractory to competition. Similarly, the presence
of a single CPD lesion within the radiolabeled 51-mer oligonu-
cleotide results in the formation of stable nucleoprotein
associations between FaXPD andDNA evenwhen the reaction
mixtures contain ATP, indicating that the helicase is stalled
at lesion sites (Figure 6A). The enzymatically inactive K48R
and K603A mutants yield always stable complexes in these
competition assays because they are unable to undergo
ATP hydrolysis-dependent translocation toward the 30 end of
DNA substrates (Figures 6B and 6C).
A completely different outcome was detected when the
Y192A and R196E mutants were probed in competition
assays. Like wild-type XPD, both mutants readily dissociate
from the radiolabeled oligonucleotide in the absence of DNA
lesions if the reactions are supplemented with ATP. However,
the Y192A and R196E derivatives are unable to form the ex-
pected stable nucleoprotein complex following ATP-driven
collisions with a CPD site. These incubations yield an incom-
plete electrophoretic mobility shift, whereby part of the radio-
labeled oligonucleotides remains in the protein-bound state
but a considerable proportion of mutant enzymes is released
from the DNA substrate (Figures 6D and 6E). The faster
migrating bands, indicated by an asterisk, represent partially
dissociated XPD-DNA complexes. Thus, the Y192A and
R196R substitutions generate XPD derivatives that interact
less efficiently with DNA damage than the wild-type control.These findings obtained in competition assays were
confirmed by testing the ability of FaXPD mutants to protect
DNA from digestion by T4 endonuclease V (T4 endo V), which
specifically recognizes and cleaves DNA at CPD positions [44].
After a 15 min preincubation of forked DNA substrate with
FaXPD, the unwinding products were probed by the addition
of T4 endo V. A CPD-dependent cleavage is indicative of
protein-free DNA regions, whereas reduced cleavage would
demonstrate occlusion of the CPD site by a close interaction
of XPD with DNA lesions. If, as shown in the denaturing gel
of Figure 6F, the preceding helicase reaction was performed
with the inactive mutants K48R and K603A, which are unable
to translocate along DNA, the CPD site in forked substrates
remained protein free and accessible to cleavage by T4 endo
V. Instead, preincubation with wild-type FaXPD restricted the
cleavage by T4 endo V, indicating that the enzyme moves
to the CPD site and forms intimate contacts with the lesion.
Preincubation with the Y192A and R196E mutants failed to
inhibit the digestion by T4 endo V, consistent with a less effi-
cient masking of CPDs compared to the reactions with wild-
type FaXPD. These results confirm that residues Y192 and
R196 are necessary to sense DNA damage during the tracking
movement of XPD and thereby generate a stable recognition
intermediate.
Discussion
This report identifies critical amino acids by which XPD dis-
criminates between undamaged and damaged DNA sub-
strates, and by replacement of the respective side chains,
we ultimately prove that this DNA helicase subunit of TFIIH
serves as a general damage verifier in the NER pathway. We
also demonstrate a previously postulated [25, 31] but thus
far unproven new mode of DNA quality control involving the
narrow protein pore of a nucleic acid-scanning enzyme.
Spontaneously formed XPD mutations in human patients,
which give rise to XP, combined XP/CS, or TTD disorders,
either cause a loss of DNA helicase activity or destabilize inter-
actions with other TFIIH subunits [14, 29–31, 38, 45]. Here, we
took a novel approach by targeting for site-directed mutagen-
esis a critical region of XPD where its DNA-binding channel
reaches a narrow protein pore, but without replacing amino
acids directly involved in ATPase and DNA helicase activity.
Utilizing this strategy, we obtained two XPD mutants (Y192A
and R196E) that retain the ability to unwind double-stranded
DNA, although they fail to sense bulky base lesions during their
ATP-driven scanning movement along nucleic acid lattices.
Moreover, in the absence of the Y192 and R196 side chains,
XPD shows a reduced ability to form stable DNA damage
recognition intermediates. We conclude from these biochem-
ical findings that residues Y192 and R196 delineate a sensor
pocket, linked to the central protein pore, which is dedicated
to the recognition of base lesions. This sensor pocket lies in
a region that had been identified, using the archaeal homolog
from Thermoplasma acidophilum, as a hot spot for interac-
tions with DNA substrates [32, 46]. In support of our findings,
Kuper et al. [32] observed previously that the T. acidophilum
Y166A mutant, which is considered equivalent to the Y192A
derivative of this report, also retains DNA helicase activity,
although to a lesser degree than the human Y192A mutant.
Our study is the first to characterize the consequences of
this Y192A mutation, and the R196E substitution, in the phys-
iologic chromatin context of living cells, thus demonstrating
that the trapping of bulky base lesions by the newly identified
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Figure 6. Immobilization of FaXPD at DNA Lesions
(A) Competition assay with wild-type FaXPD. In the
presence of ATP (3 mM), the enzyme (60 nM) rapidly
dissociates from the undamaged oligonucleotide
(5 nM), but not from the damaged counterpart contain-
ing a single CPD. –XPD, control reactions without the
addition of FaXPD; ATPgS, reactions containing nonhy-
drolyzable ATP analog.
(B and C) Competition assays with the enzymatically
inactive K48R and K603A mutants.
(D and E) Competition assays with the DNA damage-
insensitive Y192A and R196E mutants. Asterisks indi-
cate partially dissociated XPD-DNA complexes.
(F) Protection assay with T4 endo V showing that wild-
type FaXPD, but not the mutant enzymes, forms
a demarcation complex at the CPD lesion site in forked
DNA substrates.
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210sensor pocket (involving both Y192 and R196) is indeed a strict
requirement for damage excision. That XPD depends on
a dedicated recognition pocket, in addition to the protein
pore, to detect base lesions is in line with a previous report
showing that this helicase overcomes even large obstacles,
like tightly bound single-stranded DNA-binding proteins,
during its ATP-driven translocation [42].
The newly discovered DNA damage-sensing function of
XPD bears on the finding that XPC, which is the upstream initi-
ator of global genome NER activity, detects damage-induced
destabilization of the double helix rather than recognizing
abnormally modified bases [8, 35, 47]. This entirely indirect
mode of repair initiation implies that the NER machinery
must display a downstream recognition subunit that verifies
base lesions to assure the presence of chemical modifications
before carrying out the excision reaction. The critical impor-
tance of this verification mechanism is emphasized by the
finding that XPC also binds extensively to undamaged DNA,
indicating that, instead of being responsible for lesion recogni-
tion, it provides an essential but rather unspecific ‘‘match-
maker’’ for the loading of downstream NER factors onto the
DNA double helix [7, 19–24, 28, 48]. In view of these interac-
tions of XPC taking place on undamaged DNA, i.e., in the
absence of chemical modifications, it is necessary to protect
the native double helix, which is present in vast excess,
from futile excision cycles. Conversely, during transcription-coupled repair, the temporarily stalled RNA
polymerase II is removed from the template
strand to expose the substrate duplex to the
activity of TFIIH and further downstream
NER factors [25–28, 49]. Therefore, an attrac-
tive feature of lesion verification, mediated by
the tracking movement of XPD, is that in both
global genome and transcription-coupled
repair, this helicase ensures the correct timing
and spacing of DNA unwinding, thereby
providing a central decision point in the NER
reaction. With this verification mechanism,
a stably unwound DNA intermediate leading
to damage excision is only formed by
damage-specific stalling of XPD, in a way
that strand separation by TFIIH, possibly in
conjunction with additional factors like XPA
[28], is strictly focused on lesion sites. In
contrast, native regions of the double helix,
which fail to stop the XPD helicase, arebypassed by dynamically translocating TFIIH complexes
without being presented to the NER machinery.
Experimental Procedures
Materials
Simian virus 40-transformed XP-D fibroblasts (GM08207) were from the
Coriell Institute for Medical Research (Camden, NY). The expression vector
for XPD-GFP was kindly provided by W. Vermeulen (Erasmus Medical
Center, Rotterdam, the Netherlands). The pGL3 and pRL-TK vectors ex-
pressing Photinus and Renilla luciferase, respectively, were from Promega.
Cell Culture
Culture media and supplements were from Invitrogen. XP-D cells were
grown using Dulbecco’s modified Eagle’s medium, whereas V79 CHO
cells were cultured using F-12 nutrient mixture in a humidified incubator
at 37C and 5% CO2. These media were supplemented with 10% (v/v)
heat-inactivated fetal calf serum, 100 units/ml penicillin G, and 100 mg/ml
streptomycin.
DNA Repair Assays
Host-cell reactivation assays [35], CPD excision assays [24], and the immu-
nochemical analysis of spots of DNA damage and repair, generated by UV
irradiation through micropore filters, were carried out as outlined in Supple-
mental Experimental Procedures.
Image Analysis
Fluorescence measurements at UV radiation spots were performed through
a 633 oil immersion objective with a numeric aperture of 1.4 (EC Plan-
Neofluar, Zeiss) using an Ar+ source (488 nm). The average fluorescence
DNA Quality Control by XPD Helicase Sensor
211intensities were assessed in the area of CPD formation and normalized
against the background signal in a neighboring nonirradiated area of iden-
tical size. The background-corrected values are given as a percentage of
the wild-type XPD-GFP signal. In addition, the overall green fluorescence
level in the nuclei of transfected cells was analyzed, and only cells with
comparably low XPD protein expression were used for quantifications.
Live-Cell Determination of Protein Dynamics
FRAP was performed on a Leica TCS SP5 confocal microscope, operated
by Application Suite 2.6.3.8173, and equipped with an Ar+ laser and a 633
oil immersion lens (numeric aperture 1.4). Protein dynamics assays were
performed in a controlled environment (37C, 5% CO2). Briefly, transfected
CHO cells were grown on 18 mm glass coverslips. A region of interest (ROI)
of 4 mm2 was photobleached for 20 iterations at 75% laser intensity. Then,
fluorescence recoverywithin the ROI wasmonitored 200 times every 115ms
followed by 30 frames of 250 ms and 20 frames of 500 ms. The results were
adjusted for overall bleaching by correction with a reference ROI of identical
size at each time point. Finally, the first fluorescence measurement after
bleaching was set to zero and the following data were plotted as a function
of time [22, 50].
FRAP on local damage (FRAP-LD) was performed using a 403 oil immer-
sion lens (numeric aperture 1.4). In transfected CHO cells, ROIs correspond-
ing to sites of XPD-GFP accumulation were defined 30–45 min after the
induction of repair spots by irradiation through polycarbonate filters. Each
ROI was photobleached at 75% laser intensity until the fluorescence
reached a level equivalent to that outside the UV spot. Subsequently, the
fluorescence recovery was monitored ten times using 700 ms intervals
followed by eight frames of 5 s and five frames of 20 s. Concomitantly,
a reference ROI of the same sizewasmeasured to correct for overall bleach-
ing. In the data display, the first fluorescence measurement after photo-
bleaching is set to zero, and all following time points are normalized to
the prebleaching level [40, 50].
Biochemical Methods
The chromatin binding assay and characterization of purified FaXPD
proteins were carried out as described previously [24, 40] and outlined in
Supplemental Experimental Procedures.
Supplemental Information
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.cub.2012.12.032.
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